Since pyroptosis is classically activated through the NLRP3/caspase 1/GSDMD axis, several studies have investigated the efficacy of specific inhibitors targeting this axis to mitigate pyroptotic death in IHD. This evidence concerns the gene CASP1 and myocardial ischemia.